Developmental Exposure to Endocrine Disrupting Chemicals Alters the Epigenome: Identification of Reprogrammed Targets

Abstract

Endocrine disruptions induced by environmental toxicants have placed an immense burden on society to properly diagnose, treat and attempt to alleviate symptoms and disease. Environmental exposures during critical periods of development can permanently reprogram normal physiological responses, thereby increasing susceptibility to disease later in life - a process known as developmental reprogramming. During development, organogenesis and tissue differentiation occur through a continuous series of tightly-regulated and precisely-timed molecular, biochemical and cellular events. Humans may encounter endocrine disrupting chemicals (EDCs) daily and during all stages of life, from conception and fetal development through adulthood and senescence. Though puberty and perimenopausal periods may be affected by endocrine disruption due to hormonal effects, prenatal and early postnatal windows are most critical for proper development due to rapid changes in system growth. Developmental reprogramming is shown to be caused by alterations in the epigenome. Development is the time when epigenetic programs are ‘installed’ on the genome by ‘writers’, such as histone methyltransferases (HMTs) and DNA methyltransferases (DNMTs), which add methyl groups to lysine and arginine residues on histone tails and to CpG sites in DNA, respectively. A number of environmental compounds, referred to as estrogenic endocrine disruptors (EEDs), are able to bind to estrogen receptors (ERs) and interfere with the normal cellular development in target tissues including the prostate and uterus. These EEDs, including diethylstilbestrol (DES), bisphenol A (BPA), and genistein (a phytoestrogen derived from soybeans), have been implicated in the malformation of reproductive organs and later development of disease. Due to the lack of fully understanding the underlying mechanisms of how environmental toxicants and their level of exposure affect the human genome, it can be challenging to create clear clinical guidance to address the potential health effects of lower-level exposures commonly experienced within the general population. In addition, human studies concerning environmental exposures are limited in feasibility by ethical concerns for human safety. Therefore, studies in animal models provide great opportunities to reveal links between early-life exposure to EDCs and related diseases. It has been shown that developmental exposure to EDCs, such as diethylstilbestrol (DES) and genistein, during reproductive tract development increases the incidence, multiplicity and overall size of uterine fibroids in the Eker rat model, concomitantly reprogramming estrogen-responsive gene expression. Importantly, EDC exposure represses enhancer of zeste 2 (EZH2) and reduces levels of the histone 3 lysine 27 trimethylation (H3K27me3) repressive mark through Estrogen receptor / Phosphatidylinositide 3-kinases / Protein kinase B non-genomic signaling in the developing uterus. More recent research identified a developmental reprogramming target, Scbg2a1 gene, whose epigen...

Organ Toxicity and Estrogen Like Effects of Cuminum Cyminum.L Seed Essential Oil: A Hormonal, Histopathological and Immunohistochemical Study in Female Mice

“…Mild edema in endometrium and moderate edema in perimeter layers of animals which were exposed to low and medium cumin doses, as well as hyperplastic effects in endometrial epithelium of high dose group (Fig 1), confirm the endocrine disruptive effects of cumin essential oil as previous studies in rat revealed the association between early-life exposure to endocrine disruptors and overall size of uterine fibroids (23), (24).…”

Autism genes are selectively targeted by environmental pollutants including pesticides, heavy metals, bisphenol A, phthalates and many others in food, cosmetics or household products

“…Epigenetic changes have been observed in autism, and these too may be related to environmental agents [12,13] as reported for Bisphenol A and heavy metals (see Table 1) and for flame retardants and other endocrine disruptors, including soy formula and phytoestrogens such as genistein [14][15][16] and also for other nutritional agents such as Vitamin D and folic acid [17][18][19]. However, epigenetics is not the subject of this study, which is limited to the 206 autism-related polymorphic genes reported from gene association studies.…”

“…Thalidomide Prenatal use also associated with autistic features [134][135][136] The Dexamethasone treatment during pregnancy in mice ( gestational days [16][17][18][19] increases astrocyte density in the adult offspring Substantia nigra and ventral tegmental area in both males and females and increases tyrosine hydroxylase immunoreactivity in these areas in both sexes, but with a more pronounced effect on Tyrosine hydroxylase positive cell density in females [144]. Ethanol Prenatal use associated with autism [135,145] In utero exposure of mouse progeny to alcohol or methamphetamine causes postnatal neurodevelopmental deficits .…”

Impact of Drug Treatment at Neonatal Ages on Variability of Drug Metabolism and Drug-Drug Interactions in Adult Life

“…Rats exposed to bisphenol A, an endocrine disrupter found in plastic that binds and activates the nuclear estrogen receptor (ER), during their first five days of life exhibited markedly upregulated expression of the secretaglobin gene in the prostate at day 70. The increased expression correlated with persisting increased enrichment of histone H3K9 acetylation and DNA hypomethylation upstream of the gene’s transcription start site [49, 50]. The adult enzymatic activity of P450s in the liver may also be regulated by epigenetic modifications that are able to be permanently adjusted and established early in life.…”